Stock Events

Stock Events

Liminal Biosciences 

$8.5
26
+$0.01+0.12% Monday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
263.86M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

7NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-2.15
-1.48
-0.81
-0.14
Expected EPS
N/A
Actual EPS
N/A

Financials

-240.73%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
313,752.14Revenue
-755,308.31Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LMNL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Biotechnology
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Liminal BioSciences, Inc. is a biopharmaceutical corporation. The company is headquartered in Laval, Quebec and currently employs 487 full-time employees. The firm is focused on developing a pipeline of small molecule therapeutics to treat patients with liver, respiratory and kidney disease, with a focus on rare or orphan diseases. The company operates through three segments: Small Molecule Therapeutics Segment, Plasma-derived Therapeutics Segment and Bioseparations segment. The Small Molecule Therapeutics Segment is a small-molecule drug development business. The Plasma-derived Therapeutics Segment includes its plasma-derived therapeutics platform, which enables the development of its pipeline of biopharmaceutical candidates. Bioseparations segment is engaged in bioseparation, specifically for purification of biologics and the elimination of pathogens. Its product candidates include PBI-4050, PBI-4547, Ryplazim IV and Inter Alpha Inhibitor Protein (IAIP).
Show more...
CEO
Kenneth Galbraith
Employees
251
Country
CA
ISIN
CA53272L1031
WKN
000A2PTG9

Listings

0 Comments

Share your thoughts

FAQ

What is Liminal Biosciences stock price today?▼
The current price of LMNL is $8.5 USD — it has increased by +0.12% in the past 24 hours. Watch Liminal Biosciences stock price performance more closely on the chart.
What is Liminal Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Liminal Biosciences stocks are traded under the ticker LMNL.
What is Liminal Biosciences market cap?▼
Today Liminal Biosciences has the market capitalization of 263.86M
What is Liminal Biosciences revenue for the last year?▼
Liminal Biosciences revenue for the last year amounts to 313,752.14 USD.
What is Liminal Biosciences net income for the last year?▼
LMNL net income for the last year is -755,308.31 USD.
How many employees does Liminal Biosciences have?▼
As of April 02, 2026, the company has 251 employees.
In which sector is Liminal Biosciences located?▼
Liminal Biosciences operates in the Manufacturing sector.
When did Liminal Biosciences complete a stock split?▼
The last stock split for Liminal Biosciences was on February 01, 2023 with a ratio of 1:10.
Where is Liminal Biosciences headquartered?▼
Liminal Biosciences is headquartered in Laval, CA.